ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04060	Cytokine-cytokine receptor interaction	4/23	295/8135	0.008697	0.3651	0.3494	THPO/ACVR2A/TNFRSF9/CCR7	4
KEGG	hsa05133	Pertussis	2/23	76/8135	0.0192	0.3651	0.3494	C1QA/C3	2
KEGG	hsa04610	Complement and coagulation cascades	2/23	85/8135	0.02368	0.3651	0.3494	C1QA/C3	2
KEGG	hsa05171	Coronavirus disease - COVID-19	3/23	232/8135	0.02662	0.3651	0.3494	OAS2/C1QA/C3	3
KEGG	hsa05150	Staphylococcus aureus infection	2/23	96/8135	0.02969	0.3651	0.3494	C1QA/C3	2
KEGG	hsa04640	Hematopoietic cell lineage	2/23	99/8135	0.03142	0.3651	0.3494	CD1B/THPO	2
KEGG	hsa05142	Chagas disease	2/23	102/8135	0.03319	0.3651	0.3494	C1QA/C3	2
KEGG	hsa05322	Systemic lupus erythematosus	2/23	136/8135	0.05584	0.422	0.4038	C1QA/C3	2
KEGG	hsa05162	Measles	2/23	139/8135	0.05804	0.422	0.4038	OAS2/CCND2	2
KEGG	hsa05418	Fluid shear stress and atherosclerosis	2/23	139/8135	0.05804	0.422	0.4038	ACVR2A/NFE2L2	2
KEGG	hsa04936	Alcoholic liver disease	2/23	142/8135	0.06028	0.422	0.4038	C1QA/C3	2
KEGG	hsa04630	JAK-STAT signaling pathway	2/23	162/8135	0.07592	0.4372	0.4184	THPO/CCND2	2
KEGG	hsa04151	PI3K-Akt signaling pathway	3/23	354/8135	0.07603	0.4372	0.4184	PIK3R5/CCND2/COL9A2	3
KEGG	hsa04022	cGMP-PKG signaling pathway	2/23	167/8135	0.08001	0.4372	0.4184	PIK3R5/ADRA2B	2
KEGG	hsa04062	Chemokine signaling pathway	2/23	192/8135	0.1015	0.4372	0.4184	PIK3R5/CCR7	2
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	2/23	194/8135	0.1033	0.4372	0.4184	PIK3R5/C3	2
KEGG	hsa04510	Focal adhesion	2/23	201/8135	0.1096	0.4372	0.4184	CCND2/COL9A2	2
KEGG	hsa05169	Epstein-Barr virus infection	2/23	202/8135	0.1105	0.4372	0.4184	OAS2/CCND2	2
KEGG	hsa05203	Viral carcinogenesis	2/23	204/8135	0.1123	0.4372	0.4184	C3/CCND2	2
KEGG	hsa03022	Basal transcription factors	1/23	45/8135	0.1199	0.4372	0.4184	ERCC2	1
KEGG	hsa00620	Pyruvate metabolism	1/23	47/8135	0.1249	0.4372	0.4184	ACYP1	1
KEGG	hsa03420	Nucleotide excision repair	1/23	47/8135	0.1249	0.4372	0.4184	ERCC2	1
KEGG	hsa04340	Hedgehog signaling pathway	1/23	56/8135	0.1471	0.4554	0.4358	CCND2	1
KEGG	hsa05134	Legionellosis	1/23	57/8135	0.1495	0.4554	0.4358	C3	1
KEGG	hsa05131	Shigellosis	2/23	247/8135	0.1534	0.4554	0.4358	RRAGD/C3	2
KEGG	hsa00310	Lysine degradation	1/23	63/8135	0.1639	0.4554	0.4358	PRDM7	1
KEGG	hsa00830	Retinol metabolism	1/23	68/8135	0.1758	0.4554	0.4358	RDH8	1
KEGG	hsa04917	Prolactin signaling pathway	1/23	70/8135	0.1805	0.4554	0.4358	CCND2	1
KEGG	hsa04115	p53 signaling pathway	1/23	73/8135	0.1875	0.4554	0.4358	CCND2	1
KEGG	hsa05140	Leishmaniasis	1/23	77/8135	0.1967	0.4554	0.4358	C3	1
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/23	77/8135	0.1967	0.4554	0.4358	DES	1
KEGG	hsa04721	Synaptic vesicle cycle	1/23	78/8135	0.199	0.4554	0.4358	RAB3A	1
KEGG	hsa04146	Peroxisome	1/23	82/8135	0.2081	0.4554	0.4358	PEX10	1
KEGG	hsa04911	Insulin secretion	1/23	86/8135	0.2171	0.4554	0.4358	RAB3A	1
KEGG	hsa04512	ECM-receptor interaction	1/23	88/8135	0.2216	0.4554	0.4358	COL9A2	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/23	90/8135	0.226	0.4554	0.4358	DES	1
KEGG	hsa04350	TGF-beta signaling pathway	1/23	94/8135	0.2348	0.4554	0.4358	ACVR2A	1
KEGG	hsa05414	Dilated cardiomyopathy	1/23	96/8135	0.2392	0.4554	0.4358	DES	1
KEGG	hsa05165	Human papillomavirus infection	2/23	331/8135	0.24	0.4554	0.4358	CCND2/COL9A2	2
KEGG	hsa00564	Glycerophospholipid metabolism	1/23	98/8135	0.2436	0.4554	0.4358	LPGAT1	1
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	1/23	100/8135	0.2479	0.4554	0.4358	CCR7	1
KEGG	hsa05146	Amoebiasis	1/23	102/8135	0.2522	0.4554	0.4358	CD1B	1
KEGG	hsa04974	Protein digestion and absorption	1/23	103/8135	0.2543	0.4554	0.4358	COL9A2	1
KEGG	hsa04080	Neuroactive ligand-receptor interaction	2/23	353/8135	0.2634	0.4584	0.4386	C3/ADRA2B	2
KEGG	hsa05145	Toxoplasmosis	1/23	112/8135	0.2733	0.4584	0.4386	PIK3R5	1
KEGG	hsa04725	Cholinergic synapse	1/23	113/8135	0.2754	0.4584	0.4386	PIK3R5	1
KEGG	hsa04611	Platelet activation	1/23	124/8135	0.298	0.4584	0.4386	PIK3R5	1
KEGG	hsa04110	Cell cycle	1/23	126/8135	0.302	0.4584	0.4386	CCND2	1
KEGG	hsa04068	FoxO signaling pathway	1/23	131/8135	0.312	0.4584	0.4386	CCND2	1
KEGG	hsa04371	Apelin signaling pathway	1/23	139/8135	0.3276	0.4584	0.4386	PIK3R5	1
KEGG	hsa04140	Autophagy - animal	1/23	141/8135	0.3315	0.4584	0.4386	RRAGD	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	1/23	143/8135	0.3353	0.4584	0.4386	ACVR2A	1
KEGG	hsa04072	Phospholipase D signaling pathway	1/23	148/8135	0.3448	0.4584	0.4386	PIK3R5	1
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	1/23	150/8135	0.3486	0.4584	0.4386	PIK3R5	1
KEGG	hsa04145	Phagosome	1/23	152/8135	0.3524	0.4584	0.4386	C3	1
KEGG	hsa04921	Oxytocin signaling pathway	1/23	154/8135	0.3561	0.4584	0.4386	PIK3R5	1
KEGG	hsa04150	mTOR signaling pathway	1/23	156/8135	0.3598	0.4584	0.4386	RRAGD	1
KEGG	hsa04218	Cellular senescence	1/23	156/8135	0.3598	0.4584	0.4386	CCND2	1
KEGG	hsa04390	Hippo signaling pathway	1/23	157/8135	0.3616	0.4584	0.4386	CCND2	1
KEGG	hsa05160	Hepatitis C	1/23	157/8135	0.3616	0.4584	0.4386	OAS2	1
KEGG	hsa04310	Wnt signaling pathway	1/23	167/8135	0.3798	0.4584	0.4386	CCND2	1
KEGG	hsa05225	Hepatocellular carcinoma	1/23	168/8135	0.3816	0.4584	0.4386	NFE2L2	1
KEGG	hsa04530	Tight junction	1/23	169/8135	0.3834	0.4584	0.4386	CD1B	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	1/23	171/8135	0.3869	0.4584	0.4386	NFE2L2	1
KEGG	hsa05164	Influenza A	1/23	171/8135	0.3869	0.4584	0.4386	OAS2	1
KEGG	hsa05152	Tuberculosis	1/23	180/8135	0.4027	0.4671	0.447	C3	1
KEGG	hsa04621	NOD-like receptor signaling pathway	1/23	184/8135	0.4096	0.4671	0.447	OAS2	1
KEGG	hsa05168	Herpes simplex virus 1 infection	2/23	495/8135	0.4125	0.4671	0.447	OAS2/C3	2
KEGG	hsa04613	Neutrophil extracellular trap formation	1/23	190/8135	0.4198	0.4673	0.4471	C3	1
KEGG	hsa05202	Transcriptional misregulation in cancer	1/23	193/8135	0.4248	0.4673	0.4471	CCND2	1
KEGG	hsa05417	Lipid and atherosclerosis	1/23	215/8135	0.4604	0.4987	0.4772	NFE2L2	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/23	222/8135	0.4713	0.4987	0.4772	CCND2	1
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	1/23	223/8135	0.4728	0.4987	0.4772	NFE2L2	1
KEGG	hsa04714	Thermogenesis	1/23	232/8135	0.4864	0.5062	0.4844	SLC25A20	1
KEGG	hsa05012	Parkinson disease	1/23	266/8135	0.535	0.5492	0.5256	NFE2L2	1
KEGG	hsa05020	Prion disease	1/23	273/8135	0.5444	0.5516	0.5278	C1QA	1
KEGG	hsa05206	MicroRNAs in cancer	1/23	310/8135	0.5913	0.5913	0.5659	CCND2	1